In a statement the company said in the "current environment of capitalscarcity and uncertain economic conditions" it had decided to concentrate instead on developing cancer treatments.
In the 1990s a privatising government got around the scarcity of capital and know-how by coaxing state-owned pension funds to co-operate with private companies, and pushed public banks into giving them subsidised loans.